Comment on "CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study"
- PMID: 40952612
- DOI: 10.1007/s12072-025-10912-5
Comment on "CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study"
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no conflicts of interest. Ethical approval: The authors have nothing to report.
Comment on
-
CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study.Hepatol Int. 2025 Dec;19(6):1397-1411. doi: 10.1007/s12072-025-10877-5. Epub 2025 Jul 23. Hepatol Int. 2025. PMID: 40702274
References
-
- Liu Z, Li X, Huang Y, et al. CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study. Hepatol Int. 2025. https://doi.org/10.1007/s12072-025-10877-5 - DOI - PubMed
-
- Song X, Liu X, Liu F, et al. Comparison of machine learning and logistic regression models in predicting acute kidney injury: a systematic review and meta-analysis. Int J Med Inform. 2021;151: 104484. https://doi.org/10.1016/j.ijmedinf.2021.104484 - DOI - PubMed
-
- Peng J, Huang J, Huang G, et al. Predicting the initial treatment response to transarterial chemoembolization in intermediate-stage hepatocellular carcinoma by the integration of radiomics and deep learning. Front Oncol. 2021;11: 730282. https://doi.org/10.3389/fonc.2021.730282 - DOI - PubMed - PMC
-
- Xie T, Gong J, Zhao Q, et al. Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer. BMC Med Imaging. 2024;24(1):136. https://doi.org/10.1186/s12880-024-01311-7 - DOI - PubMed - PMC
Publication types
Grants and funding
- 2022-245/State Administration of Traditional Chinese Medicine of the People's Republic of China
- 202203/State Administration of Traditional Chinese Medicine of the People's Republic of China
- 2018-131/State Administration of Traditional Chinese Medicine of the People's Republic of China
- 02103021224437/Department of Science and Technology of Shanxi Province
- [2019]61/Department of Science and Technology of Shanxi Province
LinkOut - more resources
Full Text Sources
